Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 88
Filter
1.
Intern Med J ; 42(3): 306-10, 2012 Mar.
Article in English | MEDLINE | ID: mdl-20646095

ABSTRACT

BACKGROUND: Hyponatraemia is a common cause of hospitalisation in older adults. Adrenal insufficiency (AI) can result in hyponatraemia. AIM: The aim of our study was to determine the frequency and characteristics of AI in elderly patients with hyponatraemia. METHODS: Thirty patients ≥65 years with Na(+) ≤130 mmol/L and 30 age-matched control subjects, all hospitalised, were included in the study. Plasma cortisol levels were determined before and after intravenous administration of 1 µg synthetic adrenocorticotropin hormone. A peak cortisol >550 nmol/L was considered to exclude AI. RESULTS: Sodium levels were 125 ± 5 and 139.8 ± 2 mmol/L in the hyponatremic and control groups respectively. Baseline cortisol <550 nmol/L was found in a half of hyponatremic patients. However, stimulated cortisol levels were compatible with AI in only one case (3%) and none of the controls. The mean cortisol levels were significantly higher in hyponatremic compared with control subjects, both in the basal state (585 ± 215 and 381 ± 135 nmol/L, respectively, P < 0.001) and after stimulation (933 ± 254 and 781 ± 160 nmol/L, P < 0.05). However, the incremental increase in cortisol levels after stimulation was similar in the two groups (361 ± 196 and 403 ± 155 nmol/L) CONCLUSIONS: AI is an uncommon cause of hyponatraemia in older age. Based on this small cohort, AI may be present in 3% of elderly patients with hyponatraemia. AI cannot be excluded by baseline cortisol in a significant minority of hyponatremic patients and further testing with adrenocorticotropin hormone stimulation is needed.


Subject(s)
Adrenal Insufficiency/diagnosis , Adrenocorticotropic Hormone , Hyponatremia/etiology , Adrenal Insufficiency/complications , Aged , Cardiovascular Diseases/epidemiology , Case-Control Studies , Cerebrovascular Disorders/epidemiology , Female , Gastrointestinal Diseases/epidemiology , Humans , Hydrocortisone/blood , Hydrocortisone/metabolism , Inpatients , Male , Middle Aged , Potassium/blood , Selective Serotonin Reuptake Inhibitors/adverse effects , Sodium/blood , Sodium Chloride Symporter Inhibitors/adverse effects
2.
Intern Med J ; 40(8): 574-80, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20298512

ABSTRACT

BACKGROUND: Hyponatraemia is the commonest electrolyte disorder in the elderly. Data on severe hyponatraemia and the prevalence of cerebral salt wasting syndrome (CSWS) in elderly hospitalized patients are lacking. We studied the incidence, frequency of various aetiologies, outcome and the possible role of CSWS in severe hyponatraemia in elderly medical patients. METHODS: A prospective, observational, non-interventional study conducted over a 5-month period in medical wards. Eighty-six patients aged over 65 years with serum sodium levels < or =125 mEq/L were included. All patients were examined by one of the authors, who also evaluated potential contributing factors. Demographic, clinical and outcome data were extracted from the medical records. RESULTS: The mean age of the patients was 82.1 + 8.7 years. The prevalence of hyponatraemia was 6.2% (8.1% women and 4.0% men (P < 0.001)). There was no increase in incidence of hyponatraemia with age. The leading cause of hyponatraemia was the syndrome of inappropriate antidiuretic hormone secretion (SIADH), whose aetiology could be determined in only 46% of cases. Aetiology was multifactorial in 51% of patients (1.7 aetiological factors per patient). All patients with thiazide-induced hyponatraemia had other contributing factors. Hyperglycaemia and hypoalbuminaemia were predictors of neurological manifestations of hyponatraemia. Overall in-hospital mortality was 19%. Only hypoalbuminaemia was found as an independent risk factor for death. In none of the patients was the hyponatraemia due to CSWS. CONCLUSION: Severe hyponatraemia in elderly hospitalized medical patients is more frequent in women and of multifactorial aetiology in 50% of cases. It is most commonly caused by SIADH; CSWS is an unlikely cause.


Subject(s)
Hospitalization/trends , Hyponatremia/epidemiology , Hyponatremia/etiology , Severity of Illness Index , Age Factors , Aged , Aged, 80 and over , Female , Heart Failure/complications , Heart Failure/epidemiology , Hospitals, Community/trends , Humans , Hyponatremia/therapy , Male , Prevalence , Prospective Studies , Sodium Chloride Symporter Inhibitors/adverse effects , Treatment Outcome
3.
Clin Exp Rheumatol ; 26(3 Suppl 49): S30-4, 2008.
Article in English | MEDLINE | ID: mdl-18799050

ABSTRACT

OBJECTIVE: Giant cell arteritis (GCA) has a variable course. We assessed whether intensity of initial systemic inflammatory response (ISIR) can predict the course of GCA. METHODS: Charts of 130 GCA patients were reviewed. ISIR intensity at presentation was determined by 5 parameters of inflammation: sedimentation rate >100 mm/h, thrombocytosis >400,000/microl, hemoglobin <11 g/dl, leukocytosis >11000/microl, and fever >37.5 degrees C. Patients were divided into 3 groups according to ISIR intensity: strong (4-5 parameters present, n=24), moderate (2-3 parameters, n=55) and weak ISIR (0-1 parameter, n=51). RESULTS: There were no significant differences between these groups regarding mean age, female:male ratio and the initial prednisone dose. At 1 year, 75% of patients in the strong ISIR group required >5 mg/d of prednisone, compared to 54% and 37% of patients with moderate or weak ISIR, respectively (p=0.015). Disease flares were more common in patients with strong ISIR during a 3-year period, compared to patients with moderate or weak ISIR (77%, 67% and 43%, respectively, p=0.013). Only 33% of patients with strong ISIR were able to discontinue steroids after 3 years, compared to 49% and 77% of patients with moderate and weak ISIR, respectively (p=0.003). CONCLUSION: GCA Patients with strong ISIR have prolonged disease course with more flares, requiring higher steroid doses. ISIR intensity should be taken into consideration when planning studies evaluating potential steroid-sparing agents, as response to treatment may vary in patients with different ISIR intensities.


Subject(s)
Giant Cell Arteritis/physiopathology , Polymyalgia Rheumatica/physiopathology , Adrenal Cortex Hormones/administration & dosage , Aged , Aged, 80 and over , Cohort Studies , Disease Progression , Drug Administration Schedule , Female , Giant Cell Arteritis/drug therapy , Humans , Inflammation/drug therapy , Inflammation/physiopathology , Male , Middle Aged , Polymyalgia Rheumatica/drug therapy , Retrospective Studies
4.
Clin Exp Rheumatol ; 25(1 Suppl 44): S15-7, 2007.
Article in English | MEDLINE | ID: mdl-17428357

ABSTRACT

OBJECTIVE: Giant-cell arteritis (GCA) incidence is reported to be rising. A cyclic pattern of annual incidence rates and seasonal variations were reported by several groups. However, such fluctuations were not observed by others. We examined both annual and seasonal rates of GCA over a period of 25 years in Jerusalem. METHODS: Charts of all patients diagnosed as GCA between 1980-2004 were reviewed. In 170 cases GCA was biopsy-proven. Thirty-six additional cases were included as they met the American College of Rheumatology GCA classification criteria. Data on the Jerusalem population throughout the study period was collected from the annual publications of the Israel Bureau of Statistics. Age- and sex-specific incidence rates per 100000 population aged>or=50 were calculated. RESULTS: For the whole period, the average age-adjusted incidence rate was 11.3 per 100000, and 9.5 for the biopsy-positive cases. The female: male ratio was 1.4:1. Cyclic fluctuations of GCA incidence with 3 distinctive peaks, 8-10 years apart, were observed. Altogether, there was no apparent increase in GCA incidence during this period. Seasonal variations were observed: in 192 patients we were able to estimate the time of onset of GCA symptoms. It showed a peak in the months of May and June, with the number of patients being twice as expected for this period (p<0.001). CONCLUSION: GCA onset was more common in late spring and early summer, and fluctuations in GCA annual incidence with 3 distinctive peaks were observed during a 25-year period. These suggest infectious or other environmental etiology, however thus far no such agents were proven.


Subject(s)
Giant Cell Arteritis/epidemiology , Seasons , Aged , Female , Giant Cell Arteritis/pathology , Humans , Incidence , Israel/epidemiology , Male , Middle Aged
5.
Int J Clin Pract ; 61(2): 247-54, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17263711

ABSTRACT

The number of elderly patients hospitalised in acute medical wards is increasing rapidly. It is important to understand the demographic and clinical characteristics of these patients so as to plan appropriate resource allocation and geriatric training programmes. The aim of the study is to describe the demographic and clinical characteristics of elderly patients admitted to an internal medicine department. During a 3-months prospective study, 779 patients over the age of 65 with acute illness admitted to internal medicine wards. The mean age of the patients was 80 +/- 8 years; 277 (36%) were defined as dependent. The latter had significantly more moderate or severe dementia, higher APACH II scores, lower serum albumin levels, needed more mechanical ventilation, a higher mortality rate and more prolonged admissions (for all variables p < 0.001). Infectious disease was the main indication for admission in the dependent patients while in the independent patients it was cardiac disease (54 vs. 29% and 17 vs. 45%, respectively, p < 0.001). In-hospital mortality was 11%. Functional capacity during hospitalisation declined significantly in all patients but more in those over the age of 85. Of those patients discharged from hospital, mental deterioration during the hospitalisation was observed in only 3%. Our study supports the concept of the introduction of specialised geriatric facilities within the general hospital framework, including the geriatric training and education of all residents in internal medicine.


Subject(s)
Geriatrics/statistics & numerical data , Health Services for the Aged/statistics & numerical data , Hospitalization/statistics & numerical data , Internal Medicine/statistics & numerical data , Aged , Aged, 80 and over , Female , Geriatric Assessment , Hospital Mortality/trends , Humans , Israel/epidemiology , Length of Stay , Male , Prospective Studies
6.
J Eval Clin Pract ; 11(1): 33-44, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15660535

ABSTRACT

INTRODUCTION: The significant changes, which have affected departments of medicine over the last two decades, have been much editorialized. Surprisingly few data have been published that document these changes. We describe the demographic and clinical characteristics of patients admitted to one hospital's departments of internal medicine. METHODS: During a 3 months prospective study, 1039 patients (46% of all 2277 new admissions to the departments of medicine, consisting of +/- 175 beds) were randomized for inclusion. Information was extracted from the medical records regarding demography; functional capacity; clinical data and outcome. RESULTS: The mean age of the patients was 72 +/- 16 years (mean +/- SD); 51% were male, 56% were married, and 83% lived at home. Although 293 patients (28%) were defined as dependent, the majority lived at home (170, 58%). Cognition was normal in only 74%. The four most common disease categories leading to admission were infections (383 patients, 37%), cardiovascular disorders (372, 36%), respiratory conditions (284, 27%) and genito-urinary problems (90, 9%). Overall, 98 persons died (9%). Independent risk factors for death were: mechanical ventilation; a 'do not resuscitate' order; a high APACHE-II score; a low serum albumin level; higher age; and not being married (P < 0.01). CONCLUSIONS: Geriatric patients occupy a central position in our medical wards. These data are relevant for allocation of special resources for departments with high proportions of geriatric patients; for the design of employment conditions that ascertains continuing job satisfaction; as well as for the planning of teaching opportunities for residents and students.


Subject(s)
Demography , Health Status , Hospitalization/statistics & numerical data , Age Factors , Aged , Cohort Studies , Female , Hospital Mortality , Humans , Male , Prospective Studies , Treatment Outcome
7.
Ann Rheum Dis ; 62(12): 1189-94, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14644857

ABSTRACT

OBJECTIVE: To develop response criteria for polymyalgia rheumatica (PMR) for monitoring treatment and comparing alternative treatments regimens. METHODS: 76 patients, mean (SD) age 68.7 (7.7) years, were enrolled. Corticosteroids, and non-steroidal anti-inflammatory drugs (NSAIDs) were the only drugs allowed during the observation period. Erythrocyte sedimentation rate (ESR), C reactive protein (CRP), alpha(2) globulin, serum iron, pain, physician's global assessment (PGA), morning stiffness (MST), muscle tenderness (MT), myalgia, and the elevation of upper limbs (EUL) were determined regularly. The daily corticosteroid and NSAID doses as the corticosteroid response time were recorded. To ensure evaluation of an adequate number of patients (n = 57) week 24 was chosen for final analysis. RESULTS: ESR, CRP, alpha(2) globulin, pain, PGA, MST, myalgia, MT, and EUL showed significant improvement (p<0.0001) at week 24 compared with week 0. Multiple regression analysis showed that changes of ESR (p = 0.08), CRP (p = 0.41), alpha(2) globulin (p = 0.13), MST (p = 0.1), and MT (p = 0.07) were independent of pain, but myalgia (p<0.001) and EUL (p = 0.003) were pain dependent. Consequently, a core set of PMR response criteria, comprising ESR or CRP, pain, PGA, MST, and EUL was established. Assessment of treatment responses with this core set resulted in 90%, 70%, 50%, and 20% improvement in 31/57 (54%), 46/57 (81%), 51/57 (89%), and 54/57 (95%) of the patients, respectively. CONCLUSION: These PMR response criteria are a promising tool for better monitoring of disease activity and treatment in PMR. It is proposed that these criteria should be used in clinical trials in the near future to explore alternative treatment options for PMR.


Subject(s)
Polymyalgia Rheumatica/drug therapy , Adrenal Cortex Hormones/therapeutic use , Aged , Aged, 80 and over , Alpha-Globulins/analysis , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Arm/physiology , Biomarkers/blood , Blood Sedimentation/drug effects , C-Reactive Protein/analysis , Female , Humans , Male , Middle Aged , Pain/etiology , Polymyalgia Rheumatica/diagnosis , Polymyalgia Rheumatica/physiopathology , Treatment Outcome
8.
QJM ; 95(5): 291-7, 2002 May.
Article in English | MEDLINE | ID: mdl-11978900

ABSTRACT

BACKGROUND: There remain concerns about the safety of once-daily dosing of aminoglycosides (AGs) in the elderly. AIM: To assess the safety of once-daily AGs in elderly patients and evaluate possible risk factors for nephrotoxicity. DESIGN: Prospective, non-interventional surveillance study. METHODS: All patients receiving AGs were monitored over 4 months. Clinicians determined the AG dose for each patient after estimating patient weight and calculating creatinine clearance (CrCl) using the Cockcroft-Gault formula. Parallel figures were calculated by the investigators using measured weight. Clinicians obtained an AG trough level 24 h after initiation of treatment, and, if non-toxic, every 5-7 days thereafter. AG toxicity was defined as an increase in serum creatinine of > or =50%. RESULTS: In the study period, 249 consecutive patients received an AG: 116 (47%) males, mean+/-SD age 75+/-16 years. Forty-two (17%) received amikacin and 207 (83%) gentamicin. An increase of > or =50% in serum creatinine was detected in 31/249 (12.4%); maximal creatinine was < or =177 micromol/l in 16/249 (6.4%), 186-265 micromol/l in nine (3.6%), and >265 micromol/l in six (2.4%). None developed oliguric renal failure. Renal damage correlated with a high AG trough level (>1.1 microg/ml) (p<0.001); haemoglobin level <10 g/dl (p<0.05); hospital admission >7 days prior to AG treatment (p<0.005); and AG treatment > or =11 days (p<0.05). Mean CrCl based on estimated weight was 52+/-18 ml/min; that based on actual weight was 71+/-37 ml/min. Despite this, mean AG dose was 1.3+/-0.6 higher than optimal. CONCLUSIONS: Oliguric and/or lasting renal toxicity is rare in elderly patients receiving once-daily aminoglycosides for <11 days, if regular trough drug levels are monitored.


Subject(s)
Anti-Bacterial Agents/adverse effects , Kidney Diseases/chemically induced , Adult , Aged , Aged, 80 and over , Amikacin/adverse effects , Amikacin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Bacterial Infections/drug therapy , Creatinine/blood , Drug Administration Schedule , Female , Gentamicins/adverse effects , Gentamicins/therapeutic use , Humans , Kidney Diseases/blood , Male , Middle Aged , Prospective Studies , Risk Factors
9.
J Rheumatol ; 28(9): 2046-8, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11550973

ABSTRACT

OBJECTIVE: To evaluate the frequency and characteristics of visual hallucinations (VH) in patients with giant cell arteritis (GCA) and to determine their relationship to other visual phenomena. METHODS: This prospective study included 31 consecutive patients with GCA. All were asked whether they had experienced recent visual phenomena. Patients with visual symptoms underwent a comprehensive ophthalmologic examination. When unusual visual phenomena were reported, patients were asked to describe their nature, duration, and frequency of occurrence. RESULTS: Visual symptoms occurred in 6 patients: permanent visual loss in 5 and amaurosis fugax in one. In 4 of the 5 patients with permanent visual loss, it was preceded by intermittent VH over a period of 1-10 days. Patients were aware of the unreal nature of the visions. Hallucinations disappeared within 2 weeks, but in one patient, recurred 6 months later in association with further visual deterioration. CONCLUSION: The occurrence of visual hallucinations in patients with GCA-associated visual loss is more common than previously appreciated. As hallucinations preceded permanent loss of vision, this phenomenon may serve as a harbinger of imminent visual loss.


Subject(s)
Blindness/epidemiology , Giant Cell Arteritis/epidemiology , Hallucinations/epidemiology , Age Distribution , Aged , Aged, 80 and over , Blindness/diagnosis , Comorbidity , Female , Giant Cell Arteritis/diagnosis , Hallucinations/diagnosis , Humans , Incidence , Male , Middle Aged , Prognosis , Prospective Studies , Risk Factors , Severity of Illness Index , Sex Distribution
10.
Clin Nutr ; 20(6): 535-40, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11884002

ABSTRACT

OBJECTIVE: To compare the indications for and the outcome of long-term enteral feeding by nasogastric tube (NGT) with that of percutaneous endoscopic gastrostomy (PEG) tube. DESIGN: A prospective, multicenter cohort study. SETTING: Acute geriatric units and long-term care (LTC) hospitals in Jerusalem, Israel. PARTICIPANTS: 122 chronic patients aged 65 years and older for whom long-term enteral feeding was indicated as determined by the treating physician. Patients with acute medical conditions at the time of tube placement were excluded. MEASUREMENTS: We examined the indications for enteral feeding, nutritional status, outcome and complications in all subjects. Subjects were followed for a minimum period of six months. RESULTS: Although the PEG patients were older and had a higher incidence of dementia, there was an improved survival in those patients with PEG as compared to NGT (hazard ratio (HR)=0.41; 95% confidence interval (CI) 0.22-0.76; P=0.01). Also, the patients with PEG had a lower rate of aspiration (HR=0.48; 95% CI 0.26-0.89) and self-extubation (HR=0.17; 95% CI 0.05-0.58) than those with NGT. Apart from a significant improvement in the serum albumin level at the 4-week follow-up assessment in the patients with PEG compared to those with NGT (adjusted mean 3.35 compared to 3.08; F=4.982), nutritional status was otherwise similar in both groups. CONCLUSION: In long-term enteral feeding, in a selected group of non-acute patients, the use of PEG was associated with improved survival, was better tolerated by the patient and was associated with a lower incidence of aspiration. A randomized controlled study is needed to determine whether PEG is truly superior to NGT.


Subject(s)
Enteral Nutrition/methods , Intubation, Gastrointestinal/methods , Age Factors , Aged , Aged, 80 and over , Cohort Studies , Endoscopy , Female , Gastrostomy , Humans , Incidence , Intubation, Gastrointestinal/adverse effects , Male , Prospective Studies , Time Factors , Treatment Outcome
11.
J Am Geriatr Soc ; 47(11): 1337-41, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10573443

ABSTRACT

OBJECTIVES: To define longitudinal changes in the attitudes of offspring concerning life-sustaining measures for their older, terminally ill parents and to determine whether experience of a "life event" influences such decisions. DESIGN: An attitudinal survey of three groups. SETTING: The geriatric department of a university-affiliated general hospital. PARTICIPANTS: Fifty-one subjects who had been interviewed regarding life-sustaining treatment for their terminally ill parents were reinterviewed 6 years later. In addition, a control group composed of 116 participants was generated from patients visiting hospital outpatient clinics. The control group had no prior experience involving hospitalization of a first-degree relative as a result of a life-threatening situation. INTERVENTIONS: Each subject took part in a personal interview. MAIN OUTCOME MEASURES: Attitudes regarding life-sustaining measures were assessed, and the subjects' sociodemographic and religious characteristics were noted. RESULTS: The attitudes of offspring in the acute phase situation and after the passage of 6 years were strikingly consistent. Twenty-one percent had requested the initiation of resuscitation in the acute phase ("real time"), and 27.4% said the same 6 years later. The provision of nutrition and medication was requested by approximately 70% of participants both at the acute phase and 6 years later. When comparing each individual's personal views at the interviews with all others, consistency in attitude was found among answers to most questions. When comparing the acute phase group with the control group, a significantly higher percentage of the former requested the initiation of resuscitation (48.3% vs 25%), whereas a smaller percentage preferred that the decision be made by the physician (3.5% vs 21.3%). Active euthanasia was requested by 6.5% of the acute phase group and 12.9% of the control group. CONCLUSIONS: The decisions made by offspring regarding life-sustaining measures for their terminally ill parent at real time remain unchanged 6 years after the event. Exposure to a life event significantly affects the decision-making of the offspring of a terminally ill parent. However, the subject's attitude toward extreme solutions--opposing active euthanasia and requesting the administration of nutrition and medication--was not influenced by the fact that the subject had undergone a life event.


Subject(s)
Adult Children , Attitude to Health , Family , Life Support Care , Parent-Child Relations , Terminally Ill , Age Factors , Decision Making , Drug Therapy , Ethnicity , Euthanasia , Euthanasia, Active , Female , Follow-Up Studies , Humans , Interviews as Topic , Life Change Events , Longitudinal Studies , Male , Nutritional Physiological Phenomena , Professional-Family Relations , Religion , Resuscitation , Terminal Care , Withholding Treatment
12.
Isr Med Assoc J ; 1(1): 17-9, 1999 Sep.
Article in English | MEDLINE | ID: mdl-11370115

ABSTRACT

OBJECTIVES: To evaluate whether the increasing incidence of temporal arteritis in Israel is associated with a changing clinical presentation. METHODS: The demographic data and clinical manifestations of 144 TA patients in this large multicenter study were recorded and compared with data obtained in a previous study. RESULTS: The patient population was older, with 24% > or = 80 years compared to 6% in the previous study. There was an increase in the number of nonspecific presenting symptoms, and less patients presented with the "classical" manifestations of headache (81% vs. 71%), fever (83% vs. 40%), jaw claudication (21% vs. 13%), and visual symptoms (47% vs. 24%). The median time from presentation to diagnosis was significantly reduced, from 5 to 1.5 months. CONCLUSIONS: There were substantial changes in the clinical presentation of TA patients in Israel during 1980-95 compared to patients diagnosed prior to 1978. It is suggested that these changes may be attributed not only to the influence of aging of the population, but are due largely to increasing physician awareness to the spectrum of manifestations of TA, which leads to earlier diagnosis.


Subject(s)
Giant Cell Arteritis/diagnosis , Giant Cell Arteritis/ethnology , Jews/statistics & numerical data , Age Distribution , Aged , Aged, 80 and over , Female , Humans , Incidence , Israel/epidemiology , Male , Middle Aged
14.
J Am Geriatr Soc ; 46(8): 978-82, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9706886

ABSTRACT

OBJECTIVES: To analyze the clinical characteristics, associated risk factors, and outcome of hypoglycemia in nondiabetic hospitalized older patients. DESIGN: A retrospective case control study. PARTICIPANTS: Sixty patients, aged 65 years and older, in the acute medical and geriatric wards who developed hypoglycemia. A control group was composed of 83 older patients, sex and age matched, in orthopedic and surgery wards who were undergoing corrective surgery for hip fracture or hernioplasty. MEASUREMENTS: For all patients, data for the following variables were abstracted from the charts: age, sex, degree of hypoglycemia, clinical presentation of hypoglycemia, number and duration of hypoglycemia episodes, nutritional state, and blood chemistry analysis. Risk factors were defined as nutritional state, heart failure, renal or liver disease, malignancy, and infection or sepsis. RESULTS: Mean blood glucose in hypoglycemic cases was 38.9 +/- 7 mg/dL. Symptoms and signs of hypoglycemia were noted in only 38.4% (23/60) of patients. All identified risk factors except cachexia were found significantly more frequently in the hypoglycemic patients than in the control group. Mean total number of risk factors was greater in the hypoglycemic group than in the control group, 2.97 +/- 1.1 versus 1.64 +/- .8, respectively (P < .001). In a multivariant logistic model, low plasma albumin level, liver disease, malignancy, and congestive heart failure were significant predictors of hypoglycemia. In-hospital mortality rate was higher among the hypoglycemic patients, 48% versus 18.1% (P < .001), and was independent of the degree of hypoglycemia or the number of hypoglycemic episodes. Mortality was correlated significantly with the number of risk factors (3.4 +/- 1.1 vs 2.5 +/- 1.1; P = .006). Hypoglycemia remained a significant predictor of mortality (OR = 3.67; 95% CI, 1.2-11.2) even after the adjustment for other risk factors. CONCLUSIONS: Hypoglycemic episodes occur even among nondiabetic hospitalized older patients. Symptoms and signs of hypoglycemia were noted in only two-fifths of the patients. Albumin less than 3.0 g%, liver disease, renal insufficiency, malignancy, congestive heart failure, and sepsis were statistically significant predictors of developing hypoglycemia. The overall mortality rate was significantly higher among the hypoglycemic patients and was independent of hypoglycemia levels. Mean total number of risk factors was significantly higher among those who died compared with hypoglycemic patients who survived. Based on the present study, the estimated odds of mortality in an older patient with hypoglycemia were 3.67 times higher than in those without hypoglycemia.


Subject(s)
Hospitalization , Hypoglycemia/etiology , Age Factors , Aged , Aged, 80 and over , Female , Humans , Logistic Models , Male , Multivariate Analysis , Risk Factors
15.
J Med Ethics ; 24(1): 44-8, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9549682

ABSTRACT

Respecting and encouraging autonomy in the elderly is basic to the practice of geriatrics. In this paper, we examine the practice of cardiopulmonary resuscitation (CPR) and "artificial" feeding in a geriatric unit in a general hospital subscribing to jewish orthodox religious principles, in which the sanctity of life is a fundamental ethical guideline. The literature on the administration of food and water in terminal stages of illness, including dementia, still shows division of opinion on the morality of withdrawing nutrition. We uphold the principle that as long as feeding by naso-gastric (N-G) or percutaneous endoscopic gastrostomy (PEG) does not constitute undue danger or arouse serious opposition it should be given, without causing suffering to the patient. This is part of basic care, and the doctor has no mandate to withdraw this. The question of CPR still shows much discrepancy regarding elderly patients' wishes, and doctors' opinions about its worthwhileness, although up to 10 percent survive. Our geriatric patients rarely discuss the subject, but it is openly ventilated with families who ask about it, who are then involved in the decision-making, and the decision about CPR or "do-not-resuscitate" (DNR) is based on clinical and prognostic considerations.


Subject(s)
Ethics, Medical , Geriatrics/legislation & jurisprudence , Judaism , Life Support Care/legislation & jurisprudence , Paternalism , Personal Autonomy , Philosophy, Medical , Religion and Psychology , Resuscitation Orders/legislation & jurisprudence , Terminal Care/legislation & jurisprudence , Value of Life , Aged , Enteral Nutrition , Humans , Informed Consent/legislation & jurisprudence , Israel , Medical Futility , Risk Assessment , Stress, Psychological , Withholding Treatment
16.
Harefuah ; 135(9): 398-400, 1998 Nov 01.
Article in Hebrew | MEDLINE | ID: mdl-10911457
17.
J Rheumatol ; 24(8): 1659, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9263173
18.
Geriatrics ; 52(6): 38-40, 43-4, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9194789

ABSTRACT

Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are closely related disorders found predominantly in older patients. These disorders, which are being recognized more frequently, are more common in women, in Caucasians, and in various geographic locations. Early recognition and treatment may prevent possible catastrophic consequences of GCA, such as blindness, stroke, or dissection of the aorta. Although diagnosis is fairly easy with the classic presentation, it may be missed when the patient presents with nonspecific constitutional symptoms. An increased awareness among primary care physicians will aid in the prevention of much of the morbidity and mortality related to these diseases.


Subject(s)
Giant Cell Arteritis/diagnosis , Polymyalgia Rheumatica/diagnosis , Aged , Cardiovascular Diseases/diagnosis , Cerebrovascular Disorders/diagnosis , Female , Headache/diagnosis , Hearing Loss, Sensorineural/diagnosis , Humans , Middle Aged , Prognosis , Respiratory Tract Diseases/diagnosis , Synovitis/diagnosis , Vision Disorders/diagnosis
19.
Clin Exp Rheumatol ; 15(3): 303-6, 1997.
Article in English | MEDLINE | ID: mdl-9177927

ABSTRACT

OBJECTIVE: To define the optimal corticosteroid dose regimen in the initial treatment of temporal arteritis (TA). METHODS: We conducted a retrospective long-term evaluation of the efficacy and toxicity of corticosteroid treatment in 77 TA patients treated with three different dose-regimens: group A starting at 30-40 mg/d of prednisone, group B > 40-60 mg/d, and group C > 60 mg/d. RESULTS: The 3 patient groups were similar with regard to the mean age, male/female ratio, mean duration of follow-up, percentage of positive temporal artery biopsies, and rate of steroid tapering. There was a positive correlation between the starting dose and the cumulative dose of steroids at one year. Treatment efficacy was similar among the groups: cumulative cure rates (i.e. patients off steroids without exacerbation of TA for 6 months or more) were 11-13%, 29-35%, and 48-50% after 1, 2, and 3 years, respectively. In addition, the rates of disease flare were similar among the groups after 3 years of follow up, although group C patients tended to have fewer TA exacerbations during the first year compared to the other groups. In contrast, group A patients developed significantly fewer steroid side effects: 36% compared to 78% and 88% in groups B and C. CONCLUSION: The group A steroid regimen, starting with 30-40 mg/d and tapering to 10 mg/d within 6 months and to 5-7.5 mg/d within 1 year, was effective and less toxic in this patient population, than the two higher dose regimens.


Subject(s)
Anti-Inflammatory Agents/administration & dosage , Giant Cell Arteritis/drug therapy , Prednisone/administration & dosage , Aged , Anti-Inflammatory Agents/adverse effects , Anti-Inflammatory Agents/therapeutic use , Dose-Response Relationship, Drug , Female , Giant Cell Arteritis/physiopathology , Humans , Male , Prednisone/adverse effects , Prednisone/therapeutic use , Retrospective Studies , Treatment Outcome
20.
Clin Rheumatol ; 15(5): 483-5, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8894362

ABSTRACT

We have noticed significant changes in the clinical presentation in patients diagnosed with temporal arteritis in Israel between 1980-1992 compared to patients diagnosed prior to 1977. At the time of diagnosis 57% of the patients were older than 75 years, compared to only 23% within this age group in the previous period. There was an increase in the number of nonspecific and unusual presenting symptoms such as weakness, respiratory and neurological symptomatology, and a decreased proportion of patients presenting with the "classical" manifestation such as headaches, temporal tenderness and visual symptoms. The time from presentation to diagnosis was shortened significantly. It is suggested that these changes are largely due to the increasing awareness among physicians to the various manifestations of this conditions.


Subject(s)
Giant Cell Arteritis/complications , Aged , Aged, 80 and over , Awareness , Female , Giant Cell Arteritis/diagnosis , Giant Cell Arteritis/physiopathology , Humans , Israel , Male , Middle Aged , Physicians , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...